Bounced nicely off support with good finish. Low volume though. Great little compnay this with miles of cash and good revenue. Not much comping out of the company as far as hype and or news flow but obviously has a lot watching it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential